NIT
RGNX icon

NumerixS Investment Technologies’s Regenxbio RGNX Stock Holding History

NumerixS Investment Technologies’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$4K – 666
2020
Q2 		$4K Buy
+100
New +$3.73K ﹤0.01% 1030
2019
Q1 		– Sell
-1,200
Closed -$50K – 1293
2018
Q4 		$50K Buy
+1,200
New +$70.4K 0.02% 768

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

NumerixS Investment Technologies's RGNX Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Regenxbio (RGNX) in Q3 2020, closing a stake of 100 shares — an estimated $4K sold.

NumerixS Investment Technologies first reported a position in RGNX in Q4 2018 and held it in 2 quarters. The position peaked at $50K in Q4 2018. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Regenxbio position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 100 Regenxbio shares in Q3 2020, an estimated $4K.
  • NumerixS Investment Technologies first reported a position in Regenxbio in Q4 2018 and held it in 2 quarters.
  • NumerixS Investment Technologies's Regenxbio position peaked at $50K in Q4 2018.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.